Investigation of Anti-Hepatitis Delta Virus and Anti-Hepatitis C Virus in Patients with Hepatitis B Virus Infection

İstanbul Med J 2013;14(2):109-111

DOI: 10.5152/imj.2013.30

1. Artvin Devlet Hastanesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği, Artvin, Türkiye

2. İstanbul Eğitim ve Araştırma Hastanesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği, İstanbul, Türkiye

3. İstanbul Eğitim ve Araştırma Hastanesi, İç Hastalıkları Kliniği, İstanbul, Türkiye

No information available.

No information available

Received Date: 11.10.2012

Accepted Date: 02.04.2013

PDF

Cite

Request

ABSTRACT

Objective:

The aim of this study was to determine the prevalence of Hepatitis Delta Virus (HDV) and Hepatitis C Virus (HCV) in patients chronically infected with Hepatitis B Virus (HBV).

Methods:

The study was conducted on chronic hepatitis B patients followed in the Istanbul Training and Research Hospital. The prevalence of anti-HDV and anti-HCV antibodies was investigated in a total of 1339 patients with chronic hepatitis B infection.

Results:

Of the total 1339 patients testing positive for hepatitis B surface antigen (HBsAg), 46 (3.4%)were found to be seropositive for HDV, and 26 (1.9%) were seropositive for HCV.

Conclusion:

We conclude that HDV and HCV infections should be investigated in patients with chronic hepatitis B.

Keywords: Chronic hepatitis B, anti-Hepatitis D Virus (anti-HDV), anti- Hepatitis C Virus (anti-HCV), seroprevalence

Investigation of Anti-Hepatitis Delta Virus and Anti-Hepatitis C Virus in Patients with Hepatitis B Virus Infection

ABSTRACT

References